Background. Castleman disease (CD), or angiofollicular lymph-node hyperplasia, is an atypical lymphoproliferative disorder with heterogeneous clinical manifestations. Renal involvement in CD has been described in only single-case reports, which have included various types of renal diseases. Methods. Nineteen patients with histologically documented CD and renal biopsies available were included. Clinical features and renal histological findings were reviewed, and the available samples were immunolabelled with antivascular endothelial growth factor (VEGF) antibody. Results. Nineteen CD cases were identified: 89% were multicentric, and 84% were of the plasma-cell or mixed type. Four cases (21%) were associated with human immunodeficiency virus (HIV) infection. Among HIV-negative patients, two main patterns of renal involvement were found: (i) a small-vessel lesions group (SVL) (60%) with endotheliosis and glomerular double contours in all patients and with superimposed glomerular/arteriolar thrombi or mesangiolysis in most; and (ii) AA amyloidosis (20%). Renal histology was more heterogeneous among HIV-positive patients. Decreases in glomerular VEGF were observed only in some patients with SVL, whereas VEGF staining was normal in all other histological groups. Interestingly, glomerular VEGF loss associated with SVL was correlated with plasma C-reactive protein levels, a marker of CD activity. Conclusions. Small-vessel lesions are the most frequent renal involvement in CD, whereas loss of glomerular VEGF is correlated with CD activity and could have a role in SVL pathophysiology.
Introduction
Castleman disease (CD), also known as angiofollicular lymph-node hyperplasia, is an uncommon lymphoproliferative disorder with three histological variants (hyalinevascular, plasma-cell and plasmablastic) and two clinical types (localized/unicentric and diffuse/multicentric) [1] . In unicentric CD, a solitary enlarged lymph node is typically diagnosed in an asymptomatic patient, and lymphnode biopsy most frequently reveals a hyaline-vascular variant. Multicentric CD (MCD) is predominantly of the plasma-cell variant, and clinical features include generalized lymphadenopathy, organomegaly and systemic manifestations [1] . The plasmablastic variant is characteristic of human herpes virus-8 (HHV8)-associated CD, which is always multicentric. HHV8-associated CD occurs mainly in human immunodeficiency virus (HIV)-infected patients but may represent about 40% of MCD affecting HIV-negative patients. The pathophysiology of CD remains unclear. An initial step in its development appears to be B-cell overproduction of interleukin-6 (IL-6) in the lymph-node mantle zone, stimulated by HHV8 infection or by a heretofore unidentified exogenous or endogenous factor. Local IL-6 and vascular endothelial growth factor (VEGF) production induces the B-cell proliferation and vascularization that is characteristic of CD [2] .
Renal disease in CD seems to be uncommon, even though some investigators reported a high percentage (54%) of CD renal complications [3, 4] . However, a renal biopsy was rarely obtained, and only case reports were published. The aim of this study was to describe the first series of biopsy-proven renal disease associated with CD.
Materials and methods

Patients
Inclusion criteria were as follows: (i) histologically proven CD of any clinical or pathological type, and (ii) availability of renal histology. Patients were identified by a questionnaire sent to French nephrology and pathology departments. Clinical files were reviewed retrospectively. The following definitions were used: hypertension: blood pressure >140/90 mmHg or use of anti-hypertensive therapy; haemophagocytic syndrome: fever, elevated ferritinaemia, triglyceridaemia and lactate-dehydrogenase associated with cytopenia, and histological or cytological specimen (bone-marrow aspirate) showing haemophagocytic lymphohistiocytosis; biological thrombotic microangiopathy: association of anaemia, thrombocytopaenia, low haptoglobin, presence of schizocytes and elevated lactate-dehydrogenase; anti-phospholipid (APL) antibody: presence of lupus anti-coagulant, or anti-cardiolipin (positive if >40 IgG anti-phospholipid unit (GPLU) or IgM anti-phospholipid unit (MPLU)), or anti-β2GP1 antibody; the glomerular filtration rate (GFR) was estimated with the simplified modification of diet in renal disease (MDRD) formula [5] ; stage III to V chronic kidney disease: chronic renal failure with GFR < 60 mL/min/1.73 m 2 .
Histology
All biopsy specimens, regardless of the centre of origin, had a part for light microscopy (fixed and prepared using standard techniques) and a part for immunofluorescence-labelling studies (IgG, IgM, IgA, Kappa and Lambda Ig light chains, Fibrin, C3 and C1q anti-sera tests on frozen biopsies). Renal light microscopy specimens were systematically reviewed by a senior pathologist without access to the patients' files. Immunofluorescence results were transmitted by the different centres. Amyloidosis was diagnosed with congo red staining and immunohistochemically characterized with anti-serum amyloid A protein, anti-Kappa and anti-Lambda Ig light chains antibodies. Electron microscopy was available for one patient.
Immunohistochemistry VEGF expression was evaluated immunohistochemically on fixed biopsies with a monoclonal mouse antibody to VEGF (clone C1, Santa Cruz Biotechnology, Santa Cruz, CA) as previously described [6] . An independent set of archived biopsy samples was used as positive controls for VEGF immunolabelling [6] . A second set of five archived biopsies with thrombotic microangiopathy (TMA) and glomerular involvement served as controls (underlying diseases included gemcitabin administration, diarrhoea-associated TMA, pulmonary adenocarcinoma, one case each, and no underlying disease for two cases). Synaptopodin was labelled with a monoclonal anti-synaptopodin antibody (clone G1D4, Progen Biotechnik, Heidelberg, Germany) as previously described [7] .
Image cytometry
VEGF immunolabelling was quantified by image cytometry with the CAS 200 image analyser (Becton-Dickinson, Leiden, Netherlands) as previously described [6] . To further improve the sensitivity of glomerular VEGF detection, we optimized the acquisition threshold; thus, the normal level of glomerular VEGF expression in control biopsies was approximately 20% in our study.
Statistical analyses
A two-sided χ 2 test was used to compare all qualitative variables. MannWhitney rank testing was applied for all comparisons of quantitative variables. The results are expressed as mean values unless stated otherwise. A P-value <0.05 was considered statistically significant.
Results
Patients
Nineteen patients (10 women) were included in this study ( Table 1 ). The racial distribution was 12 Caucasians, 6
Blacks and 1 Asian. Renal biopsies were obtained between 1990 and 2008. Three cases were reported previously [8] [9] [10] . None was a renal graft recipient. Their median age was 41.5 (range 17-79) years. The median followup was 50 (range 2-180) months. CD was multicentric for 89% of the patients. Three patients (16%) had the pure hyaline-vascular variant, while other cases were plasma-cell, mixed or plasmablastic variants. Four patients were HIV-positive (21%). All HIV-positive patients had positive plasma HHV8 polymerase chain reaction (PCR) or serology, but only two were HIV-negative patients (Table 1) .
HIV-negative patients
Among these 15 patients, CD was unicentric in two and multicentric in 13 ( Table 1) . HHV8 PCR or serology was available for 10 patients and positive only in two. Plasmacell or mixed variants were the main CD histological type (12 cases, 80%), while the pure hyaline-vascular variant was observed in three patients (20%).
Renal histological features defined different patient groups ( Table 2) : patients 1-9 (60%) had small-vessel lesions (SVL) with endotheliosis and glomerular double contours in all patients and TMA or mesangiolysis in most of them; patients 10-12 (20%) were diagnosed with AA amyloidosis; patients 13 and 14 (13%) had tubulo-interstitial cellular infiltration with normal glomeruli; patient 15 had classical focal and segmental glomerulosclerosis (FSGS).
Small-vessel lesions group. Among the nine patients, six were female. The median age was 39 (range 17-79) years, and the median follow-up was 53 (range 2-180) months. CD and renal involvement diagnoses were usually concomitant (Table 1 ). All patients had multicentric CD, with seven (78%) having a plasma-cell or mixed variant and only two having the hyaline-vascular type. HHV8 PCR or serology was available in five patients and was positive in one. All but one were hypertensive and had proteinuria, and 78% suffered from renal insufficiency. Only one patient (patient 3) had biological signs of haemolytic uraemic syndrome (HUS). No malignant hypertension was observed. No other apparent cause of HUS was identified, including drug-induced HUS, infection-associated HUS or APL syndrome (although APL antibodies were present in one patient). Complement factors H and I, and ADAMTS-13 activity were within their normal ranges when available (patient 4, no serum available for others). Histological examination of the renal biopsies disclosed endothelial swelling in all patients' specimens ( Figure 1 ). In addition, all nine had glomerular capillary-loop double contours, and in four patients mesangiolysis was observed ( Figure 1 ). Glomerular fibrin thrombi were seen in patients 6 and 7 ( Figure 1) , and preglomerular arteriolar fibrin thrombi were found in patients 8 and 9. Arteriolar obstruction caused by endothelial swelling and mucoid deposits was observed in patients 8 and 9. The immunofluorescence study was positive for fibrin in arterioles and glomerular capillaries (patients 7, 8, 9) , and immune deposits were never observed ( Figure 1 ). Electron microscopy was available for patient 6, and it showed swollen endothelial cells Renal involvement in Castleman disease 601 Table 2 . with cytoplasmic vacuolization and lucent subendothelial spaces with amorphous and fibrinous deposits (described in ref. [9] ). All patients were treated with corticosteroids and/or etoposide. They all improved their renal function except patient 6. They achieved CD remission and had generally favourable outcomes except patients 3, 5 and 6, who died of metastatic gastric cancer (patient 3) and unknown causes (patients 5 and 6).
AA amyloidosis. Three HIV-negative patients had amyloidosis (Table 1) . These deposits were immunohistochemically characterized as AA amyloidosis. The median age Renal 
HIV-positive HHV8-co-infected patients
CD was diagnosed before the renal biopsy in three of these four patients. CD was multicentric for all four, and the histological variant was plasmablastic. The immunovirological status was highly variable (CD4 lymphocyte count ranged from 64 to 760/mm 3 , and the HIV load ranged from 0 to 5 log10/mL). Two patients had haemophagocytic syndrome. Oedema or anasarca was always observed, as was severe proteinuria (range 1.5 to 14 g/day). Half of these patients suffered from renal insufficiency. Patient 18 had severe renal tubular acidosis.
The histological features of HIV-positive patients were heterogeneous ( Table 2) . Patient 16 had moderate AA amyloidosis glomerular deposits. Patient 17 had normal glomeruli without any immunofluorescence-detected deposits compatible with minimal change disease or even FSGS (electron microscopy was not available). FSGS found in patient 18 was associated with unspecific cellular tubulointerstitial infiltrative lesions. Patient 19, who had severe renal tubular acidosis, had collapsing FSGS associated with monotypic immunoglobin (IgM lambda) tubular basement membrane deposits, without any glomerular deposits.
All patients were receiving highly active anti-retroviral therapy. Patient 16 received multiple courses of chemotherapy because of several relapses, and dialysis was started 39 months after renal biopsy. Patient 17 died of sepsis 32 months after CD diagnosis, after multiple courses of chemotherapy. Patients 18 and 19 underwent splenectomy and received chemotherapy, and they had subsequent stable renal function but persistent proteinuria.
Comparative analyses
Results of statistical analyses are summarized in Table 3 . No significant between-group differences were found for age, sex or overall mortality. Mean proteinuria was higher in the amyloidosis group than the SVL group, while differences in hypertension did not reach significance. GFR reduction was more severe in the amyloidosis group, and stage III to V chronic kidney disease (CKD) at the end of follow-up was significantly more frequent in the amyloidosis group than in the SVL group.
Immunolabelling
VEGF immunolabelling was performed in the 10 cases who had samples available and in the five renal samples from patients with non-CD-associated TMA. Results are summarized in Figures 2 and 3 . VEGF labelling was dramatically decreased in two patients with SVL ( Figure 2A ). For patients other than SVL patients, VEGF labelling was obvious and similar to that of normal kidneys ( Figure 2B , C and E). Normal VEGF expression was also seen in three cases of non-CD-associated TMA used as controls ( Figure 2D ), whereas two cases showed decreased VEGF expression. Synaptopodin expression, which is another podocyte marker, remained normal in CD-associated-SVL and non-CD-associated TMA, indicating that the decreased VEGF did not reflect podocyte loss in glomeruli (Supplementary Figure 1) . Notably, for the SVL group only, the glomerular VEGF labelling was negatively correlated with the plasma CRP level (R 2 = 0.8463, P = 0.0094) (Figure 3 ).
Discussion
This retrospective study identified 19 cases of CD with biopsy-proven renal involvement. Their detailed histological features, outcomes and treatments are described. The details of three of these cases had been previously published (patients 3, 6, 8), but their follow-up periods are now much long- er and had not been reported on previously [8] [9] [10] . Despite the relatively small number of patients, this study represents the largest CD population with renal involvement reported to date. Most of our patients had multicentric CD (89%), and plasma cell or plasmablastic histological variants (84%), indicating that renal involvement develops in the most aggressive types of CD. Indeed, only one of our patients had the unicentric hyaline-vascular type, which is the most frequent type of CD [2] . Nonetheless, a renal disorder was diagnosed before CD and led to the CD diagnosis in nine patients (47%). Two groups of patients are distinguished: (i) HIVnegative patients, who had relatively homogeneous renal lesions, and (ii) HIV-positive patients, who were always co-infected with HHV8 and had heterogeneous renal lesions. The predominant histological renal presentation was SVL, associated with favourable renal prognosis. The second renal disease was AA amyloidosis of poor renal prognosis. VEGF glomerular expression was decreased only in some patients with SVL. Moreover, in this group, the loss of VEGF expression was correlated with elevation of plasma CRP level, a marker of CD activity [11, 12] .
Small-vessel lesions
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HIV-negative patients. Renal SVL in CD patients had an unusual appearance, with predominantly glomerular involvement. Glomerular capillary lumens were narrowed or non-visible, and marked endothelial swelling and the double contours of the glomerular basement membrane (GBM) were always present (and were confirmed by electron microscopy when available). Severe mesangiolysis was frequently observed, as were glomerular or arteriolar thrombi. Two patients had only glomerular endotheliosis and GBM double contours, without any thrombi or mesangiolysis, which could represent the initial SVL then culminating in TMA. and SVL, combined with renal remission following treatment of CD, argue for a non-fortuitous association. Besides, no other apparent aetiology of microvascular involvement was identified in our patients, including malignant hypertension-related, drug-induced, infection-associated or APL syndrome-associated microvascular involvement. Endothelial swelling and capillary-loop double contours observed in our patients were reminiscent of renal lesions seen in preeclampsia, in which a VEGF antagonist plays a key pathophysiological role [13] . Renal TMA with endothelial swelling was described as a side effect of anti-VEGF antibody therapy [14] [15] [16] . TMA lesions were also reported during sirolimus administration and thought to be a consequence of the drug-associated decrease of podocyte VEGF expression [6] . Even slight glomerular VEGF diminution could induce renal TMA [17] . In two of our six patients with SVL and available VEGF immunolabelling, glomerular vascular lesions were associated with diminished glomerular VEGF expression, whereas synaptopodin, another podocyte marker, remained normal. Loss of glomerular VEGF was not observed in three control samples of TMA without CD, which, as previously reported, suggested that loss of VEGF expression was not a consequence of renal TMA [6] . In addition, in adult mice, podocyte-specific VEGF deletion results in profound thrombotic glomerular injury, confirming that local VEGF loss within the glomeruli suffices to trigger TMA pathogenesis [14] . Despite the limitations of this study including the small number of patients, the lack of samples for immunohistochemistry in several cases and the retrospective design, we hypothesize that CD-dependent dysregulation of renal VEGF could play a role in SVL. However, the lack of a correlation between VEGF expression and the severity of the microvascular lesions (such as in patients 4 and 5) implies that there are additional unidentified pathophysiological factors. Interestingly, two cases of non-CD-associated TMA showed decreased VEGF and normal synaptopodin expression, suggesting that loss of VEGF expression in TMA may not be restricted to CD-associated TMA.
Glomerular VEGF expression has also been studied in a case of CD-associated microangiopathy with slightly elevated CRP. Seida et al. reported glomerular expression of VEGF mRNA and protein, but the expression levels were not quantified or compared to normal controls [18] . Unfortunately, this makes it difficult to compare podocyte VEGF expression and its correlation with CRP from this interesting case to our results.
The link between CD and loss of glomerular VEGF expression in patients with SVL lesions remains elusive. Notably, we showed that the plasma CRP level, a marker of CD activity [11, 12] , correlates significantly with loss of glomerular VEGF. This result suggests that, in this subset of CD patients, lymphoproliferation may induce a downregulation of glomerular VEGF through the action of an undetermined circulating factor. VEGF itself could play such a role, considering its high level of expression in the plasma cells of lymph nodes from CD patients and the higher serum levels of VEGF in these patients [19] . Unfortunately, we could not determine the systemic levels of VEGF in our SVL patients due to the absence of historic samples. However, by analogy to those patients diagnosed with CD or POEMS syndrome with renal involvement, we speculate that the levels of VEGF were elevated in these patients [20] .
Our model implies that downregulation of glomerular VEGF induces SVL despite high levels of circulating VEGF. This result suggests that glomerular VEGF production is more important for the integrity of the glomerular endothelium than the presence of systemic VEGF. Our model also suggests that SVL could develop in patients undergoing pharmacological impairment of circulating VEGF or in women with pregnancy-associated impairment of circulating VEGF, especially if these situations were accompanied by a concomitant glomerular downregulation of VEGF. If confirmed by future studies, this hypothetical mechanism provides an explanation for the variable susceptibility of patients to developing renal microvascular disease when receiving anti-VEGF medications.
Another plausible cause for the decreased glomerular VEGF expression is the role of high levels of IL-6 produced by CD lymphoproliferation. Similar to VEGF, we were unable to measure systemic levels of IL-6 in our patients. Nonetheless, CRP reflects the level of IL-6 in CD patients, and we assume that the glomerular loss of VEGF might correlate with high circulating levels of IL-6 in our patients with SVL [21] . Symptoms of CD have also been correlated with serum IL-6 levels in humans [22] . Furthermore, animal models of IL-6 overexpression suggest that this cytokine may have a role in CD pathophysiology [23] . Besides, renal involvement in these models and in our SVL patients display similar features [23, 24] . Thus, IL-6 and/or other soluble factors secreted by the CD cells represent interesting candidates for future investigation of renal SVL mechanism and podocyte VEGF regulation [21] .
Marked endothelial swelling, severe mesangiolysis and GBM double contours were similar to those observed in the POEMS syndrome [25] [26] [27] . Indeed, our patients 5 and 6, diagnosed with SVL, had POEMS syndrome. Thus, the renal histological features of the POEMS syndrome and CD are similar, and SVL are likely the main lesions in this setting. This finding underscores the continuum between POEMS syndrome and CD [28] , highlighting the specificity of these renal lesions, and it suggests that there are common pathogenic pathways of kidney involvement for both of these diseases.
AA amyloidosis in HIV-negative patients
AA amyloidosis was the leading cause of renal disease in previously studied CD patients (11 cases reported). Among our HIV-negative patients, however, only three (20%) were diagnosed with AA amyloidosis, which represents the second common cause of CD renal involvement. Two of them developed AA amyloidosis associated with unicentric and intra-abdominal CD. Unicentric abdominal CD could remain asymptomatic, and this undiagnosed chronic inflammatory syndrome could contribute to AA amyloidosis development [29] [30] [31] [32] [33] . CD was diagnosed after AA amyloidosis for all three patients. As a consequence, although rare, CD should be considered a potential underlying disease of newly diagnosed AA amyloidosis [34] . In our study, AA amyloidosis was associated with poorer renal outcomes Renal involvement in Castleman disease 607 when compared with SVL. However, CD treatment could improve renal function, as it did for our patient 1, whose nephrotic syndrome regressed after unicentric CD excision and rituximab treatment. Cases of renal amyloidosis with symptoms regressing after unicentric CD surgery, despite no changes in renal histological features, have been described previously [21, 31, 35] . Factors directly ascribed to CD, such as IL-6, could play a role in the development of kidney AA amyloidosis or its clinical manifestations such as proteinuria and renal failure [21, 36] .
HIV-infected HHV8-co-infected patients
The four HIV-positive patients had four different renal lesions, which might be attributable to their HIV infection or to the haemophagocytic syndrome and not specifically associated with CD [37] . Of note, patient 18's severe renal tubular acidosis was associated with IgM lambda tubular basement membrane deposits, which corresponded to the isotype of the HHV8-infected B cells [38] . We hypothesize that there is a pathophysiological role of CD in this particular type of nephropathy. To our knowledge, no case of biopsy-proven CD-associated renal involvement in an HIV-positive patient has been reported.
Conclusion
We have delineated the pattern of kidney involvement in CD, with the main renal presentation being SVL with predominantly glomerular involvement. Our data led us to hypothesize that glomerular VEGF decrease could contribute to SVL in some CD patients. A systematic investigation of patients with renal disorder and CD is mandated to test this model. Whether or not a VEGF pathway could be important in some other causes of renal TMA requires further investigation. The findings of this study open new perspectives in TMA pathophysiology that might eventually lead to new treatment strategies.
